Position in GRAL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$819
+$199 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#326
of 371 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tidemark, LLC holds $110,967 across 11 Diagnostics & Research names. GRAL ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
325 | $57,144 | |
| 2 | DHR |
Danaher Corp /De/
|
88 | $16,762 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
26 | $13,035 | |
| 4 | GH |
Guardant Health, Inc.
|
50 | $7,501 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
26 | $5,896 | |
| 6 | WAT |
Waters Corp /De/
|
14 | $5,250 | |
| 7 | LH |
Labcorp Holdings Inc.
|
12 | $3,360 | |
| 8 | GRAL |
GRAIL, Inc.
This page
|
12 | $819 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $819 | 12 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $620 | 12 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,626 | 19 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,123 | 19 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $976 | 19 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $485 | 19 | Shares | Sole | 2025-05-09 | |
| 2024-09-30 | $481 | 35 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,244 | 81 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||